BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 17846769)

  • 41. Comparison between contrast-enhanced magnetic resonance imaging and technetium 99m glucohepatonic acid single photon emission computed tomography with histopathologic correlation in gliomas.
    Kumar RA; Khandelwal N; Sodhi KS; Pathak A; Mittal BR; Radotra BD; Suri S
    J Comput Assist Tomogr; 2006; 30(5):723-33. PubMed ID: 16954918
    [TBL] [Abstract][Full Text] [Related]  

  • 42. I-123-lodo-alpha-methyl tyrosine SPECT in non-parenchymal brain tumours.
    Matheja P; Weckesser M; Rickert Ch; Franzius Ch; Palkovic S; Riemann B; Schober O
    Nuklearmedizin; 2002; 41(4):191-6. PubMed ID: 12224403
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Action and efficacy of p-[131I]iodo-L-phenylalanine on primary human glioma cell cultures and rats with C6-gliomas.
    Romeike BF; Hellwig D; Heimann A; Kempski O; Feiden W; Kirsch CM; Samnick S
    Anticancer Res; 2004; 24(6):3971-6. PubMed ID: 15736441
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Kinetic parameters of 3-[(123)I]iodo-L-alpha-methyl tyrosine ([(123)I]IMT) transport in human GOS3 glioma cells.
    Riemann B; Kopka K; Stögbauer F; Halfter H; Ketteler S; Phan TQ; Franzius C; Weckesser M; Ringelstein EB; Schober O
    Nucl Med Biol; 2001 Apr; 28(3):293-7. PubMed ID: 11323240
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Kinetics of 3-[(123)I]iodo-l-alpha-methyltyrosine transport in rat C6 glioma cells.
    Riemann B; Stögbauer F; Kopka K; Halfter H; Lasic M; Schirmacher A; Kuwert T; Weckesser M; Ringelstein EB; Schober O
    Eur J Nucl Med; 1999 Oct; 26(10):1274-8. PubMed ID: 10541825
    [TBL] [Abstract][Full Text] [Related]  

  • 46. SPECT studies of brain tumors with L-3-[123I] iodo-alpha-methyl tyrosine: comparison with PET, 124IMT and first clinical results.
    Langen KJ; Coenen HH; Roosen N; Kling P; Muzik O; Herzog H; Kuwert T; Stöcklin G; Feinendegen LE
    J Nucl Med; 1990 Mar; 31(3):281-6. PubMed ID: 2155314
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Uptake of DL-3-123I-iodo-alpha-methyltyrosine in recurrent brain tumors].
    Guth-Tougelidis B; Müller S; Mehdorn MM; Knust EJ; Dutschka K; Reiners C
    Nuklearmedizin; 1995 Apr; 34(2):71-5. PubMed ID: 7761277
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Imaging gliomas with positron emission tomography and single-photon emission computed tomography.
    Bénard F; Romsa J; Hustinx R
    Semin Nucl Med; 2003 Apr; 33(2):148-62. PubMed ID: 12756647
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Para-[(123)I]iodo-L-phenylalanine in patients with pancreatic adenocarcinoma: tumour uptake, whole-body kinetics, dosimetry.
    Hellwig D; Gouverneur E; Schaefer A; Raedle J; Menges M; Kirsch CM; Samnick S
    Nuklearmedizin; 2008; 47(5):220-4. PubMed ID: 18852930
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Whole-body kinetics and dosimetry of L-3--123I-iodo-alpha-methyltyrosine.
    Schmidt D; Langen KJ; Herzog H; Wirths J; Holschbach M; Kiwit JC; Ziemons K; Coenen HH; Müller-Gärtner H
    Eur J Nucl Med; 1997 Sep; 24(9):1162-6. PubMed ID: 9283111
    [TBL] [Abstract][Full Text] [Related]  

  • 51. An interindividual comparison of O-(2-[18F]fluoroethyl)-L-tyrosine (FET)- and L-[methyl-11C]methionine (MET)-PET in patients with brain gliomas and metastases.
    Grosu AL; Astner ST; Riedel E; Nieder C; Wiedenmann N; Heinemann F; Schwaiger M; Molls M; Wester HJ; Weber WA
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):1049-58. PubMed ID: 21570201
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prognostic significance of amino acid transport imaging in patients with brain tumors.
    Weckesser M; Matheja P; Schwarzrock A; Rickert CH; Sträter R; Palkovic S; Riemann B; Kopka K; Lüdemann P; Paulus W; Wassmann H; Schober O
    Neurosurgery; 2002 May; 50(5):958-64; discussion 964-5. PubMed ID: 11950398
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Increased tumor uptake of 3-(123)I-Iodo-L-alpha-methyltyrosine after preloading with amino acids: an in vivo animal imaging study.
    Lahoutte T; Caveliers V; Franken PR; Bossuyt A; Mertens J; Everaert H
    J Nucl Med; 2002 Sep; 43(9):1201-6. PubMed ID: 12215559
    [TBL] [Abstract][Full Text] [Related]  

  • 54. 3-[123I]iodo-alpha-methyl-L-tyrosine transport and 4F2 antigen expression in human glioma cells.
    Langen KJ; Bonnie R; Mühlensiepen H; Jansen P; Bröer S; Holschbach M; Coenen HH
    Nucl Med Biol; 2001 Jan; 28(1):5-11. PubMed ID: 11182559
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Efficacy of systemic radionuclide therapy with p-131I-iodo-L-phenylalanine combined with external beam photon irradiation in treating malignant gliomas.
    Samnick S; Romeike BF; Lehmann T; Israel I; Rübe C; Mautes A; Reiners C; Kirsch CM
    J Nucl Med; 2009 Dec; 50(12):2025-32. PubMed ID: 19910430
    [TBL] [Abstract][Full Text] [Related]  

  • 56. High uptake of L-3-[123I]iodo-alpha-methyl tyrosine in pilocytic astrocytomas.
    Weckesser M; Matheja P; Rickert CH; Sträter R; Palkovic S; Löttgen J; Kurlemann G; Paulus W; Wassmann H; Schober O
    Eur J Nucl Med; 2001 Mar; 28(3):273-81. PubMed ID: 11315593
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Differential diagnosis between recurrence of gliomas and radiation necrosis by 201TlCl SPECT].
    Nakamura O; Kosuda S; Okamoto K; Kaneko M; Nakamura H; Shitara N; Suzuki K
    No To Shinkei; 1994 Nov; 46(11):1051-7. PubMed ID: 7873278
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparative biodistribution study of the new tumor tracer [123I]-2-iodo-L-phenylalanine with [123I]-2-iodo-L-tyrosine.
    Kersemans V; Cornelissen B; Kersemans K; Dierckx RA; De Spiegeleer B; Mertens J; Slegers G
    Nucl Med Biol; 2006 Jan; 33(1):111-7. PubMed ID: 16459266
    [TBL] [Abstract][Full Text] [Related]  

  • 59. 18F-fluoro-L-thymidine and 11C-methylmethionine as markers of increased transport and proliferation in brain tumors.
    Jacobs AH; Thomas A; Kracht LW; Li H; Dittmar C; Garlip G; Galldiks N; Klein JC; Sobesky J; Hilker R; Vollmar S; Herholz K; Wienhard K; Heiss WD
    J Nucl Med; 2005 Dec; 46(12):1948-58. PubMed ID: 16330557
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Analysis of 18F-FET PET for grading of recurrent gliomas: is evaluation of uptake kinetics superior to standard methods?
    Pöpperl G; Kreth FW; Herms J; Koch W; Mehrkens JH; Gildehaus FJ; Kretzschmar HA; Tonn JC; Tatsch K
    J Nucl Med; 2006 Mar; 47(3):393-403. PubMed ID: 16513607
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.